Start-up in de kijker: Creative Therapy
![creative_therapy_0.png](/sites/default/files/styles/snov_paragraph_image_scale_novs_w28/public/2022-09/creative_therapy_0.png?itok=agwJ04Io 28w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w33/public/2022-09/creative_therapy_0.png?itok=zqiOFeOT 33w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w39/public/2022-09/creative_therapy_0.png?itok=zA_F3hLG 39w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w47/public/2022-09/creative_therapy_0.png?itok=mxmWIGAP 47w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w56/public/2022-09/creative_therapy_0.png?itok=w-eRII_x 56w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w66/public/2022-09/creative_therapy_0.png?itok=HjcUPBn- 66w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w78/public/2022-09/creative_therapy_0.png?itok=K9wHntP9 78w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w92/public/2022-09/creative_therapy_0.png?itok=1QC8VA4R 92w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w94/public/2022-09/creative_therapy_0.png?itok=yKt0l1cD 94w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w109/public/2022-09/creative_therapy_0.png?itok=kzr0l0Vd 109w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w112/public/2022-09/creative_therapy_0.png?itok=oCOs8TcD 112w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w129/public/2022-09/creative_therapy_0.png?itok=sGqE_QW2 129w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w132/public/2022-09/creative_therapy_0.png?itok=eHflsNJd 132w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w152/public/2022-09/creative_therapy_0.png?itok=mrJWWVT3 152w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w156/public/2022-09/creative_therapy_0.png?itok=sfGZPEbO 156w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w179/public/2022-09/creative_therapy_0.png?itok=QpefUFkZ 179w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w184/public/2022-09/creative_therapy_0.png?itok=VkbavhrO 184w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w211/public/2022-09/creative_therapy_0.png?itok=8LjSYT2l 211w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w218/public/2022-09/creative_therapy_0.png?itok=qdnhOXni 218w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w249/public/2022-09/creative_therapy_0.png?itok=X-gezsoF 249w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w258/public/2022-09/creative_therapy_0.png?itok=idhCgq9t 258w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w294/public/2022-09/creative_therapy_0.png?itok=om4yPkGJ 294w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w304/public/2022-09/creative_therapy_0.png?itok=VsRmGmpp 304w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w346/public/2022-09/creative_therapy_0.png?itok=J0xryRTD 346w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w358/public/2022-09/creative_therapy_0.png?itok=tOlKVkCl 358w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w408/public/2022-09/creative_therapy_0.png?itok=b6uQ2DfL 408w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w422/public/2022-09/creative_therapy_0.png?itok=wUPd06Hj 422w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w481/public/2022-09/creative_therapy_0.png?itok=-o_SXy7O 481w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w498/public/2022-09/creative_therapy_0.png?itok=xnQceSwk 498w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w567/public/2022-09/creative_therapy_0.png?itok=BIw1CfqM 567w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w588/public/2022-09/creative_therapy_0.png?itok=Ykugy9Vk 588w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w668/public/2022-09/creative_therapy_0.png?itok=-Azd07H3 668w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w692/public/2022-09/creative_therapy_0.png?itok=jhGUno6R 692w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w787/public/2022-09/creative_therapy_0.png?itok=c9w0H7PB 787w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w816/public/2022-09/creative_therapy_0.png?itok=JZZFI78g 816w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w927/public/2022-09/creative_therapy_0.png?itok=Zy_m0YbV 927w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w962/public/2022-09/creative_therapy_0.png?itok=bJIdAhJa 962w, /sites/default/files/styles/snov_paragraph_image_scale_novs_w1134/public/2022-09/creative_therapy_0.png?itok=7AgZ4qki 1000w)
Naam van de start-up
Creative Therapy
https://www.mycreativetherapy.com/
Namen van de oprichters & contactgegevens-
Arno Penders arno@mycreativetherapy.com
Jamil Joundi Jamil.Joundi@UGent.be
Sebastien Michiels Sebastien@mycreativetherapy.com
Jelle Saldien Jelle.Saldien@UGent.be
INTERACTIEVE TOOLS VOOR REVALIDATIETHERAPIE
![creative_therapy_2.png](/sites/default/files/styles/snov_paragraph_text_image_scale_novs_w28/public/2022-09/creative_therapy_2.png?itok=ikESPNdd 28w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w34/public/2022-09/creative_therapy_2.png?itok=orcFPvY6 34w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w40/public/2022-09/creative_therapy_2.png?itok=ByuufIHe 40w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w48/public/2022-09/creative_therapy_2.png?itok=KGQf0vaH 48w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w56/public/2022-09/creative_therapy_2.png?itok=b5Aj-bX- 56w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w57/public/2022-09/creative_therapy_2.png?itok=yqHAFRLH 57w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w68/public/2022-09/creative_therapy_2.png?itok=_n8Nq8i1 68w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w80/public/2022-09/creative_therapy_2.png?itok=C1E7mgxt 80w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w81/public/2022-09/creative_therapy_2.png?itok=F-_zIuGs 81w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w96/public/2022-09/creative_therapy_2.png?itok=ZJosGUnm 96w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w113/public/2022-09/creative_therapy_2.png?itok=VGBBK1aS 113w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w114/public/2022-09/creative_therapy_2.png?itok=gr5bjCZO 114w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w134/public/2022-09/creative_therapy_2.png?itok=qSqMV7LI 134w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w136/public/2022-09/creative_therapy_2.png?itok=Q8YjF2-S 136w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w158/public/2022-09/creative_therapy_2.png?itok=jaKGFGKq 158w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w162/public/2022-09/creative_therapy_2.png?itok=3hjGizP8 162w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w187/public/2022-09/creative_therapy_2.png?itok=u9akeZIv 187w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w192/public/2022-09/creative_therapy_2.png?itok=jOfJwwgm 192w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w221/public/2022-09/creative_therapy_2.png?itok=W5BnHTB7 221w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w226/public/2022-09/creative_therapy_2.png?itok=hun7LxUH 226w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w260/public/2022-09/creative_therapy_2.png?itok=M90x695d 260w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w268/public/2022-09/creative_therapy_2.png?itok=fXNfCgjX 268w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w307/public/2022-09/creative_therapy_2.png?itok=JsROUZ-H 307w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w316/public/2022-09/creative_therapy_2.png?itok=6z9Ci24c 316w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w362/public/2022-09/creative_therapy_2.png?itok=LXlkyIGU 362w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w374/public/2022-09/creative_therapy_2.png?itok=kB7OVifN 374w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w427/public/2022-09/creative_therapy_2.png?itok=RlsA0FCd 427w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w442/public/2022-09/creative_therapy_2.png?itok=O1lA02KZ 442w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w503/public/2022-09/creative_therapy_2.png?itok=Om5rjlTD 503w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w520/public/2022-09/creative_therapy_2.png?itok=clC52p29 520w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w592/public/2022-09/creative_therapy_2.png?itok=MQyB03xW 592w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w614/public/2022-09/creative_therapy_2.png?itok=1VWV1ZVF 614w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w697/public/2022-09/creative_therapy_2.png?itok=KpgqgknX 697w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w724/public/2022-09/creative_therapy_2.png?itok=7ertgv6G 724w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w854/public/2022-09/creative_therapy_2.png?itok=-46MYKom 820w)
Sinds wanneer ben je gestart?
We zijn opgericht op 4 April 2019 maar het project startte al in 2015 tijdens onze studie aan UGent.
Wat heeft je gedreven om zelf te gaan ondernemen?
Ik was, voor Creative Therapy, eigenlijk helemaal geen ondernemend type. Maar toen ik in 2015 tijdens een schoolopdracht met Creative Therapy begon, geloofde ik echt in de toegevoegde waarde die dit product zou kunnen leveren aan therapeuten en hun patiënten. Hoe meer we met de markt begonnen af te stemmen, hoe groter die overtuiging werd. Ik geloof in ondernemen voor een betere wereld en dat is ook mijn drijfveer.
De “elevator pitch” van je start-up: Omschrijf in enkele zinnen de activiteit van je start-up.
Creative Therapy ontwikkelt interactieve tools voor revalidatietherapie. Ons eerste product ‘Matti’ is een interactieve spelmat die de patiënten motiveert en hun kinesisten meer inzicht geeft in hun vooruitgang tijdens de therapie.
![winwinner_0.png](/sites/default/files/styles/snov_paragraph_text_image_scale_novs_w28/public/2022-09/winwinner_0.png?itok=P_4iprTv 28w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w34/public/2022-09/winwinner_0.png?itok=PQWI5lDz 34w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w40/public/2022-09/winwinner_0.png?itok=OuSRGXHS 40w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w48/public/2022-09/winwinner_0.png?itok=eRAowX8J 48w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w56/public/2022-09/winwinner_0.png?itok=t9ewU84D 56w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w57/public/2022-09/winwinner_0.png?itok=iWAl6Jrb 57w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w68/public/2022-09/winwinner_0.png?itok=mumCr0kK 68w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w80/public/2022-09/winwinner_0.png?itok=oe6H8tRy 80w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w81/public/2022-09/winwinner_0.png?itok=bn2o4_ye 81w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w96/public/2022-09/winwinner_0.png?itok=7_2pMBtI 96w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w113/public/2022-09/winwinner_0.png?itok=ZHZ_LZCu 113w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w114/public/2022-09/winwinner_0.png?itok=Fll1nDaT 114w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w134/public/2022-09/winwinner_0.png?itok=tr-JzR-l 134w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w136/public/2022-09/winwinner_0.png?itok=oWsvNqaa 136w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w158/public/2022-09/winwinner_0.png?itok=MECwcOyx 158w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w162/public/2022-09/winwinner_0.png?itok=om_oJ8Nf 162w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w187/public/2022-09/winwinner_0.png?itok=sybnHxNw 187w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w192/public/2022-09/winwinner_0.png?itok=UwhIVo03 192w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w221/public/2022-09/winwinner_0.png?itok=Myy0ZtSe 221w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w226/public/2022-09/winwinner_0.png?itok=6dFhFKrf 226w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w260/public/2022-09/winwinner_0.png?itok=5uDU4DO2 260w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w268/public/2022-09/winwinner_0.png?itok=pgYPCFXf 268w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w307/public/2022-09/winwinner_0.png?itok=TZkQqoFs 307w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w316/public/2022-09/winwinner_0.png?itok=913LC19d 316w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w362/public/2022-09/winwinner_0.png?itok=YpW4Q8YT 362w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w374/public/2022-09/winwinner_0.png?itok=vKWWEcCX 374w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w427/public/2022-09/winwinner_0.png?itok=AxRs7wxW 427w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w442/public/2022-09/winwinner_0.png?itok=dBgbCUaS 442w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w503/public/2022-09/winwinner_0.png?itok=C_EkPTTH 503w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w520/public/2022-09/winwinner_0.png?itok=VPCuGk-M 520w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w592/public/2022-09/winwinner_0.png?itok=BaF5x_CJ 592w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w614/public/2022-09/winwinner_0.png?itok=liCI8nRz 593w)
HELP MEE AAN ONZE GROEI VIA EEN WINWIN-LENING
We zijn ook net begonnen met een winwincampagne. Hierbij krijgt iedereen de mogelijkheid om mee te helpen aan onze groei via een winwin-lening.
Wat zijn je ambities op lange termijn en de belangrijkste uitdagingen om deze ambities te realiseren.
Wij hebben net Matti in de markt kunnen zetten, maar willen niet bij dit éne product stoppen. Ons team is nu reeds begonnen met onderzoek naar nieuwe oplossingen voor de revalidatiewereld. Met Creative Therapy willen we mensen helpen en problemen oplossen. Daarom zal het belangrijk zijn om focus te houden op onderzoek.
Welk advies wil je graag meegeven aan ondernemers-in-spe?
Aan ondernemers-in-spe zou ik graag meegeven om te luisteren naar je potentiële klanten en de verzamelde data goed te analyseren. Mischien zit er wel meer achter wat ze zeggen? Om de befaamde Henri Ford te quoten: “If I had asked people what they wanted, they would have said faster horses.”
Op welke manier levert BHIC voor u concrete toegevoegde waarde bij het realiseren van je start-up ambities?
Wij hebben al een heel traject achter de rug met BHIC. Wij hebben deelgenomen aan Health RampUp, het acceleratie programma van BHIC waarbij we dieper op de health market zijn ingegaan. Daar hebben we gezien wie onze potentiële klanten waren en hoe we met hen moesten communiceren.
FUNDING OPGEHAALD VIA IMEC.ISTART EN BLUEHEALTH INNOVATION FUND
![logo_istart_en_bhif.png](/sites/default/files/styles/snov_paragraph_text_image_scale_novs_w28/public/2022-09/logo_istart_en_bhif.png?itok=FV3ZjEcq 28w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w34/public/2022-09/logo_istart_en_bhif.png?itok=LpotjuiB 34w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w40/public/2022-09/logo_istart_en_bhif.png?itok=9z-o0RBY 40w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w48/public/2022-09/logo_istart_en_bhif.png?itok=5eNy9zWN 48w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w56/public/2022-09/logo_istart_en_bhif.png?itok=Fzd4LYP2 56w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w57/public/2022-09/logo_istart_en_bhif.png?itok=krCM1wTX 57w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w68/public/2022-09/logo_istart_en_bhif.png?itok=LpKqu_4d 68w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w80/public/2022-09/logo_istart_en_bhif.png?itok=469-uEc9 80w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w81/public/2022-09/logo_istart_en_bhif.png?itok=NVgbRO0G 81w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w96/public/2022-09/logo_istart_en_bhif.png?itok=NqA6eOS3 96w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w113/public/2022-09/logo_istart_en_bhif.png?itok=Jj91WK5_ 113w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w114/public/2022-09/logo_istart_en_bhif.png?itok=ZGSOTZPa 114w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w134/public/2022-09/logo_istart_en_bhif.png?itok=ZEph3CXb 134w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w136/public/2022-09/logo_istart_en_bhif.png?itok=jExLAd6N 136w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w158/public/2022-09/logo_istart_en_bhif.png?itok=vO0BS8z2 158w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w162/public/2022-09/logo_istart_en_bhif.png?itok=AORLqQKH 162w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w187/public/2022-09/logo_istart_en_bhif.png?itok=SvVFTE7Z 187w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w192/public/2022-09/logo_istart_en_bhif.png?itok=SkwiXN4T 192w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w221/public/2022-09/logo_istart_en_bhif.png?itok=NnQA3LvX 221w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w226/public/2022-09/logo_istart_en_bhif.png?itok=ciecgMZg 226w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w260/public/2022-09/logo_istart_en_bhif.png?itok=BecJqJxB 260w, /sites/default/files/styles/snov_paragraph_text_image_scale_novs_w268/public/2022-09/logo_istart_en_bhif.png?itok=SGi-Sqnt 263w)
Daarna hebben we funding opgehaald via het imec.istart programma (70K), hierbij heeft het BHIF ook nog een extra 50K gefund. Nu heb ik nog steeds op wekelijkse basis contact met Maarten en Tom over interessante events waar Creative Therapy aan kan deelnemen. Onlangs wonnen we een Pitchwedstrijd bij PwC, waarvoor BHIC ons had geselecteerd.
Heb je nog specifieke noden waar het BHIC je mee kan helpen om je start-up te ondersteunen?
Op dit moment zijn we bezig met een winwincampagne. BHIF kan ons zeker helpen om mee onze boodschap te verspreiden. Graag had ik iemand van het BHIC willen uitnodigen om op ons investeerdersevent aanwezig te zijn.